JU
Jupiter Neurosciences, Inc.
JUNS · NASDAQ
$3.01 -12.75% (-$0.44)
1M -34.17%
Market Cap $1.65M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 25.55x
P/E N/A
P/FFO N/A
Growth
0 /100
Declining Rev. growth 54.62%
EPS growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 88.34%
FCF margin 11,206.00%
Net margin 14,220.10%
Quality
0 /100
Poor ROIC 709.40%
Asset turnover 0.02x
ROA 247.39%
Debt
7 /100
High Current ratio 0.66x
Int. coverage -262.75x
Debt/Equity N/A
Stability
4 /100
Unstable Beta 1.79x
Profitable years 0
EPS volatility 126.84%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre JUNS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christer Rosen
Employees
5
Headquarters
Jupiter
Evenimente viitoare
02 DEC.
Earnings
Upcoming earnings report